Entera Bio (ENTX) Retained Earnings (2017 - 2026)
Entera Bio (ENTX) recorded quarterly Retained Earnings of $41000.0 in Q1 2026, little changed on a QoQ basis from $41000.0 in Q4 2025, and up 100.04% year-over-year from $20496.4 in Q1 2025.
Entera Bio (ENTX) Retained Earnings (2017 - 2026) Analysis & Trends
Entera Bio has disclosed Retained Earnings across 9 years of filings, most recently posting $41000.0 for Q1 2026.
- Quarterly Retained Earnings rose 100.04% year-over-year to $41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41000.0 (up 100.04% YoY) and the FY2025 annual result came in at $41000.0, up 100.04% from the prior year.
- Retained Earnings was little changed at $41000.0 in Q1 2026, from $41000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $41000.0 in Q4 2022 and troughed at -$122.4 million in Q3 2025.
- A 5-year average of -$74.2 million and a median of -$97.7 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 100.05% — and 2025, when it plunged 284246.34%.
- Tracing ENTX's Retained Earnings over 5 years: stood at $41000.0 in 2022, then sank by 254700.0% to -$104.4 million in 2023, then declined by 9.14% to -$113.9 million in 2024, then surged by 100.04% to $41000.0 in 2025, then changed by 0.0% to $41000.0 in 2026.
- Business Quant data shows ENTX's Retained Earnings at $41000.0 in Q1 2026, $41000.0 in Q4 2025, and -$122.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | 41,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | -122.40 Mn |
| Jun 30, 2025 | -119.15 Mn |
| Mar 31, 2025 | -116.50 Mn |
| Dec 31, 2024 | -113.93 Mn |
| Sep 30, 2024 | -111.57 Mn |
| Jun 30, 2024 | -108.50 Mn |
| Mar 31, 2024 | 41,000.00 |
| Dec 31, 2023 | -104.39 Mn |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | -100.00 Mn |
| Mar 31, 2023 | -97.69 Mn |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | -92.50 Mn |
| Jun 30, 2022 | -89.40 Mn |
| Mar 31, 2022 | -86.21 Mn |
| Dec 31, 2021 | -82.43 Mn |
| Dec 31, 2020 | -70.24 Mn |
| Dec 31, 2018 | 13.02 Mn |